<DOC>
	<DOCNO>NCT01027858</DOCNO>
	<brief_summary>The investigator conduct proof-of-concept study provide preliminary evidence efficacy aerobic-based exercise training maintain cognitive function , executive function , everyday function adult mild vascular cognitive impairment .</brief_summary>
	<brief_title>PROMOTE : Promotion Mind Through Exercise</brief_title>
	<detailed_description>A total 70 adult diagnose Ischaemic Vascular Cognitive Impairment ( SIVCI ) randomize either 6 month thrice weekly walk program usual care . After 6 month intervention , follow additional 6 month . There three measurement session : baseline , 6 month ( end intervention period ) ; 12 month .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>The study specifically recruit individual fulfill diagnostic criterion SIVCI outline Erkinjuntti colleague ( 1 ) , require presence cognitive syndrome ( define Section A ) small vessel ischaemic disease ( defined Section B ) . A. Cognitive Syndrome define : 1 . Dysexecutive Syndrome : Some impairment goal formulation , initiation , planning , organize , sequence , execute , setshifting maintenance , abstract . 2 . Memory Deficit : Some impairment recall , relative intact recognition , less severe forgetting , benefit cue . 3 . Progression : Deterioration A1 A2 previous high level function per se interfere complex occupational social activity . B . Small Vessel Ischaemic Disease define : 1 . Evidence relevant cerebrovascular disease brain imaging ( last 12 month ) define presence : i. Periventricular deep white matter lesion : Patchy area low attenuation ( intermediate density normal white matter intraventricular cerebrospinal fluid ) diffuse symmetrical area low attenuation ill define margin extend centrum semiovale plus least one lacunar infarct ( correlate white matter grade scale great 3 Cardiovascular Health Study ) ( 2,3 ) ; ii . Absence cortical and/or corticosubcortical nonlacunar territorial infarct watershed infarct , haemorrhage indicate large vessel disease , sign normal pressure hydrocephalus , specific cause white matter lesion ( e.g. , multiple sclerosis , leukodystrophies , sarcoidosis , brain irradiation , etc ) . 2 . Presence history neurological sign evidence cerebrovascular disease hemiparesis , low facial weakness , Babinski sign , sensory deficit , dysarthria , gait disorder , extrapyramidal sign consistent subcortical brain lesion ( ) . In addition , individual must meet follow inclusion criterion : 1 . Montreal Cognitive Assessment ( MoCA ) ( 4 ) score le 26 screening ; 2 . MMSE ( 5 ) score &gt; 20 screening ; 3 . Communitydwelling ; 4 . Lives Metro Vancouver ; 5 . Have caregiver , family member , friend interact him/her weekly basis ; 6 . Able comply schedule visit , treatment plan , trial procedure ; 7 . Must able read , write , speak English psychometric test provide acceptable visual auditory acuity ; 8 . Stable fix dose cognitive medication ( e.g. , donepezil , galantamine , rivastigmine , memantine , etc . ) expect change 12month study period , , medication , expect start 12month study period ; 9 . Provide personally sign date informed consent document indicate individual ( legally acceptable representative ) inform pertinent aspect trial . In addition , assent form provide baseline regular interval ; 10 . Able walk independently ; 11 . Must sufficient health participate study ` aerobicbased exercise training program . This base medical history , vital sign , physical examination study physician , write recommendation family physician indicate individual ` appropriateness participate aerobicbased exercise training program . 1 . Absence relevant small vessel ischaemic lesion exist brain compute tomography ( CT ) MRI ; 2 . Diagnosed another type dementia ( e.g. , AD ) neurological condition ( e.g. , multiple sclerosis , Parkinson 's disease , etc . ) affect cognition mobility ; 3 . At high risk cardiac complication exercise and/or unable selfregulate activity understand recommend activity level ( i.e. , Class C American Heart Risk Stratification Criteria ) ; 4 . Have clinically significant peripheral neuropathy severe musculoskeletal joint disease impairs mobility ; 5 . Taking medication may negatively affect cognitive function , anticholinergic , include agent pronounce anticholinergic property ( e.g. , amitriptyline ) , major tranquilizer ( typical atypical antipsychotic ) , anticonvulsant ( e.g. , gabapentin , valproic acid , etc . ) ; 6 . Individual plan participate enrolled clinical drug trial concurrent study .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>exercise</keyword>
	<keyword>aerobic exercise training</keyword>
	<keyword>vascular cognitive impairment</keyword>
	<keyword>Mild Sub-cortical Ischaemic Vascular Cognitive Impairment ( SIVCI )</keyword>
</DOC>